A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL

Clinical trial NCT06363994 · RECRUITING

Trial details

NCT number: NCT06363994
Sponsor: InnoCare Pharma Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2024-05-29
Primary completion: 2031-06-25
Enrollment: 476

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.